Risk factors for morbidity in infants undergoing tetralogy of fallot repair

Alexander C Egbe1, Alexander J Mittnacht1, Khanh Nguyen1

  • 1Division of Pediatric Cardiology, Mount Sinai Hospital, One Gustave Levy Place, New York, NY.

Insights

Primary repair of Tetralogy of Fallot (TOF) is safe with low mortality. Patient age and weight at surgery are key predictors of intensive care unit (ICU) morbidity following this procedure.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Surgery
  • Neonatal Intensive Care

Background:

  • Tetralogy of Fallot (TOF) repair has low surgical mortality.
  • Significant postoperative morbidity can still occur in some patients.
  • Understanding predictors of morbidity is crucial for optimizing outcomes.

Purpose of the Study:

  • To review institutional experience with primary TOF repair.
  • To identify predictors of intensive care unit (ICU) morbidity after primary TOF repair.

Main Methods:

  • Retrospective study of patients undergoing primary TOF repair in infancy.
  • Analysis of preoperative, operative, and postoperative data.
  • Logistic regression used to identify predictors of prolonged ICU stay and mechanical ventilation.

Main Results:

  • Ninety-seven patients underwent primary repair with no early surgical mortality.
  • Median ICU stay was 6 days; median ventilation duration was 19 hours.
  • Patient age and weight independently predicted ICU length of stay; surgical era predicted ventilation duration.

Conclusions:

  • Primary TOF repair is a safe procedure with outcomes comparable to national standards.
  • Age and weight at surgery are significant predictors of postoperative morbidity.
  • Continued focus on patient-specific factors is important for minimizing ICU morbidity.
Abstract

Related Concept Videos

Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
422
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
602
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.8K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
5.2K
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
535